173 related articles for article (PubMed ID: 6772950)
1. Cost effectiveness of vaccination against pneumococcal pneumonia.
Willems JS; Sanders CR; Riddiough MA; Bell JC
N Engl J Med; 1980 Sep; 303(10):553-9. PubMed ID: 6772950
[TBL] [Abstract][Full Text] [Related]
2. [The cost-effectiveness of pneumococcal vaccination in Catalonia].
Plans Rubió P; Garrido Morales P; Salleras Sanmartí L
Rev Esp Salud Publica; 1995; 69(5):409-17. PubMed ID: 8564860
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
Fedson DS
Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
[TBL] [Abstract][Full Text] [Related]
4. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
5. [Cost effectiveness of pneumococcal vaccine (author's transl)].
Levy E
Rev Epidemiol Sante Publique; 1981; 29(2):133-53. PubMed ID: 6792664
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of vaccination against pneumococcal pneumonia: an update.
Sisk JE; Riegelman RK
Ann Intern Med; 1986 Jan; 104(1):79-86. PubMed ID: 3079638
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries.
Ament A; Baltussen R; Duru G; Rigaud-Bully C; de Graeve D; Ortqvist A; Jönsson B; Verhaegen J; Gaillat J; Christie P; Cifre AS; Vivas D; Loiseau C; Fedson DS
Clin Infect Dis; 2000 Aug; 31(2):444-50. PubMed ID: 10987703
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
Simberkoff MS
Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
[TBL] [Abstract][Full Text] [Related]
10. [Cost-benefit analysis of vaccination against pneumococcal pneumonia].
Ament AJ; Sprenger M; Botman MJ; Sasburg RH; de Waard J
Ned Tijdschr Geneeskd; 1986 Mar; 130(9):407-10. PubMed ID: 3083271
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps.
Vold Pepper P; Owens DK
Clin Infect Dis; 2000 Jan; 30(1):157-64. PubMed ID: 10619745
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
13. An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting.
Mangtani P; Roberts JA; Hall AJ; Cutts FT
Int J Epidemiol; 2005 Jun; 34(3):565-74. PubMed ID: 15764694
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal vaccination.
Williams RM
Lippincotts Prim Care Pract; 1998; 2(6):625-33. PubMed ID: 9883157
[TBL] [Abstract][Full Text] [Related]
16. Influenza and pneumococcal vaccination of the elderly: newer vaccines and prospects for clinical benefits at the margin.
Fedson DS
Prev Med; 1994 Sep; 23(5):751-5. PubMed ID: 7845953
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects.
Claes C; Reinert RR; von der Schulenburg JM
Eur J Health Econ; 2009 Feb; 10(1):25-38. PubMed ID: 18379830
[TBL] [Abstract][Full Text] [Related]
18. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
Weycker D; Richardson E; Oster G
Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
[TBL] [Abstract][Full Text] [Related]
19. The assessment of pneumococcal vaccine.
Austrian R
N Engl J Med; 1980 Sep; 303(10):578-80. PubMed ID: 7402223
[No Abstract] [Full Text] [Related]
20. A cost-benefit analysis of immunization for pneumococcal pneumonia.
Patrick KM; Woolley FR
JAMA; 1981 Feb; 245(5):473-7. PubMed ID: 6779017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
